Bacteria belonging to the former genus Pseudomonas was recently modifi
ed with the creation of several genus including Pseudomonas, Stenotrop
homonas, Burkholderia, Ralstonia, Comamonas... The complexity of these
novel genus is in fact masked by the predominance of a single bacteri
al species, P. aeruginosa. Several French and foreign multicentric sur
veys focused on the importance of Gram-negative and non fermenters bac
illi in infections. In the last decade, acquired resistance has been c
haracterized by the emergence of new enzymatic mechanisms, formerly un
suspected, in several countries (among which Turkey and Japan): PER-1
(class A), OXA-11, OXA-14, and OXA-18 (class D), or IMP-1 (class B). T
hese novel beta-lactamases mediate broad resistance to beta-lactams as
third generation cephalosporins including ceftazidime, and even carba
penems (IMP-1). Nevertheless, the expression level of resistance may b
e unsuspected because highly variable. Unfortunately this bacterial sp
ecies can cumulate other resistance mechanisms to aminoglycosides and
fluoroquinolones (single mutation for the corresponding DNA gyrase gen
e or gyrA or/and topo-isomerase IV gene named parC). Such acquired mul
tiresistance was mainly related to hospital environment, to hospitaliz
ation unit, and finally according to the patient's underlying diseases
. This is related to selective pressure of antibiotics. In conclusion,
choosing the adequate treatment is related to the identification of r
esistance mechanisms, at least for some antibiotics such as beta-lacta
ms, it is also related to complementary laboratory tests such as killi
ng curves of antibiotic combination.